Challenge How do you build patient segments in a largely underdiagnosed population? See how one brand team used a novel way to quantify and understand meaningful patient...
Challenge How can we increase treatment access through commercial targeting when prescribing influence is complex? A pharma brand team was launching a new mechanism of action for...
Challenge Which oncology KOLs should we prioritize for a variety of launch planning use cases? The oncology team at a large pharmaceutical company was gearing up for multiple...
Challenge Market Sizing: How can we size our potential market when the population is difficult to define? A launch planning team for a new metabolic treatment faced a big question: How...
Challenge The brand director in the lifecycle management division of a large pharmaceutical company was challenged to find new revenue opportunities for a cardiology drug that had reached maturity in...
Challenge A mid-sized pharmaceutical company acquired the U.S. rights for a product in a market with just one competitor, but was lacking the market knowledge to position the drug. Before starting...
Challenge The oncology team at a large pharmaceutical company was looking to optimize market position on several fronts: Defend its territory as a first-line therapy for indication #1 Uncover...
Challenge: The chief strategy officer at a large pharmaceutical company needs to have up-to-date knowledge regarding broad trends in immuno-oncology development activities. The chief strategy officer...
Case Study: Mapping the Clinical Path in Rheumatoid Arthritis with Real World Data The growing accessibility of healthcare Real World Data (RWD) has opened up previously unimaginable resources for...